Intimation of Schedule of Analyst(s) /Investor(s) meeting

Date: August 04, 2026 The Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 544611 (BSE SME) Subject: Intimation of Schedule of Investor(s)/Analyst(s) Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the management of the Company will have a virtual meeting with Investors as per following schedule. Date Time Type of Meeting Mode Friday, 07th August, 2026 04:00 pm (IST) Group Meeting Through Video onwards Conferencing During the aforesaid investor meet, no unpublished price sensitive information will be shared or discussed. The Discussions with the Investors/Analyst(s) would be based on publicly available information. We attach herewith the communication on the schedule of Investor Meet. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz www.mahamayalifesciences.com Note: The meeting may be cancelled, rescheduled, or postponed due to exigencies on the part of Analyst, Investor and/or the Company management. Kindly take the above information on record. Thanking you For Mahamaya Lifesciences Limited Krishnamurthy Ganesan Managing Director DIN: 00270539